Biomerica reported $1,034,450 in first quarter net sales, compared to $1,013,739 in the same period last year.
The company reported a net loss of $219,268, primarily due to an increase in research and development. The majority of research and development funds were focused on the company’s new gastroenterology test.
More articles on gastroenterology:
ACG, Smart Clinic strike deal for software marketing, distribution
11 statistics on gastroenterologist & payer relationships
3 ways gastroenterologists can demonstrate value
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
